Precision Oncology Program
Pan-Cancer (All tumor types with actionable mutations)
CommercialActive
Key Facts
Indication
Pan-Cancer (All tumor types with actionable mutations)
Phase
Commercial
Status
Active
Company
About Oncompass Medicine
Oncompass Medicine is a Budapest-based precision oncology company leveraging artificial intelligence to interpret complex genomic data and recommend personalized cancer treatments. Its flagship offering is a comprehensive Precision Oncology Program, which includes consultation, molecular diagnostics planning, and treatment selection powered by its proprietary Genomate AI software. The company has established key European partnerships with diagnostic and data firms and has been recognized as a 'Future Unicorn,' positioning it at the intersection of AI, diagnostics, and clinical decision support in oncology.
View full company profile